Results

Total Results: 1,080 records

Showing results for "submit".

261. Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: An Update of the PTSD Repository Evidence Base (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd4-final-protocol.pdf
     October 01, 2022 - included in the prior report will be notified of their study’s inclusion in the report,10 and invited to submit … Peer reviewers who disclose potential business or professional conflicts of interest can submit comments

262. Nonopioid Pharmacologic Treatments for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonopioid-pharm-chronic-pain-protocol.pdf
     February 01, 2019 - Evidence And Data for Systematic review (SEADS): Manufacturers of included drugs will be invited to submit … Peer reviewers who disclose potential business or professional conflicts of interest may submit comments

263. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_disposition-comments.pdf
     September 01, 2011 - Commentators are not required to provide their names or affiliations in order to submit suggestions

264. Disposition of Comments Report for Interventions for Feeding and Nutrition in Cerebral Palsy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cerebral-palsy-feeding_disposition-comments.pdf
     March 20, 2013 - Commentators are not required to provide their names or affiliations in order to submit suggestions

265. Medical Therapies for Children With Autism Spectrum Disorder—An Updaterum Disorder--An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/asd-medical-disposition.pdf
     May 26, 2017 - Commentators are not required to provide their names or affiliations in order to submit suggestions

266. Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetic-neuropathy-disposition-170707.pdf
     March 24, 2017 - Commentators are not required to provide their names or affiliations in order to submit suggestions

267. Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetic-neuropathy-disposition-170707.pdf
     March 24, 2017 - Commentators are not required to provide their names or affiliations in order to submit suggestions

268. The Evidence-Based Care Challenge: A Case Study (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ebc-challenge-case-130621.pdf
     June 01, 2013 - A multi-step process would have allowed teams to submit a concept proposal 13 and then, if selected

269. Effectiveness of Screening and Treatment of Subclinical Hypothyroidism or Hyperthyroidism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypothyroidism-hyperthyroidism-screening-treatment_disposition-comments.pdf
     February 01, 2012 - Commentators are not required to provide their names or affiliations in order to submit suggestions

270. Disposition of Comments for Technical Brief 25 Disparities within Serious Mental Illness (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/mental-illness-disparities_disposition-comments.pdf
     May 26, 2016 - Commentators are not required to provide their names or affiliations in order to submit suggestions

271. Cancer-Drugs-Utilization-Cost Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization-cost_research.pdf
     January 01, 2011 - Utilization and cost of anticancer biologic products among Medicare beneficiaries, 2006-2009 Data Points #6Anticancer Biologics From 2006 to 2009, over 800,000 Medicare fee-for-service beneficiaries continuously enrolled in Parts A and B had a claim for an anticancer biologic of interest. Bevacizumab was the m…

272. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_disposition-comments.pdf
     March 10, 2010 - Using terms such as "chemoprevention" and the suggestion that women should submit to this sort of "

273. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pain-chronic_disposition-comments.pdf
     September 01, 2011 - Commentators are not required to provide their names or affiliations in order to submit suggestions

274. Disposition of Comments Report for Procalcitonin-Guides Antibiotic Therapy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer78_procalcitonin_disposition_20121210.pdf
     October 05, 2012 - Commentators are not required to provide their names or affiliations in order to submit suggestions

275. Disposition of Comments Report for CER 132 Combination Therapy Versus Intensification of Statin Monotherapy: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_disposition-comments.pdf
     September 01, 2014 - Commentators are not required to provide their names or affiliations in order to submit suggestions … We also submit that such conclusions should be presented in the full context of the available evidence … We respectfully submit that as to this comparison of serious adverse events, both the draft review’ … As to this comparison of serious adverse events using the data described, we submit that the correct … difference in serious adverse events, or a meta- analysis finding a significant combined effect, we submit

276. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd-disposition-120104.pdf
     April 01, 2011 - Commentators are not required to provide their names or affiliations in order to submit suggestions

277. Disposition of Comments for CER 175 Total Worker Health (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/worker-health_disposition-comments.pdf
     May 31, 2016 - Commentators are not required to provide their names or affiliations in order to submit suggestions … Unlike clinical trials where publication is required, corporations are likely to develop and submit

278. Future Research Needs for Diagnosis of Obstructive Sleep Apnea (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/sleep-apnea-diagnosis-future_research.pdf
     February 01, 2012 - panelists were asked to review, discuss and nominate for prioritization CER-derived FRN topics, as well as submit … Throughout the open discussion period, stakeholders could use SharePoint to submit new FRN topics; a … After stakeholders submitted their disclosure of interest statements, we invited them to submit FRN … Throughout the stakeholder panel discussion period, stakeholders were invited to submit new FRN topics … regularly encouraged (two to four times per week) to contribute to the discussion boards as well as submit

279. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - Arthritis and Nontraumatic Joint Disease AHRQ Healthcare Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 01: Arthritis and Nontraumatic Joint Disease Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither…

280. Disposition of Comments for Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer: An Update of a 2008 Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_disposition-comments.pdf
     December 16, 2014 - information is provided, but commentators are not required to provide their names or affiliations to submit … Commentator & Affiliation Section Comment Response General Thank you for the opportunity to submit